OLANZAPINE TEVA ® 15 MG

Country: Израел

Језик: Енглески

Извор: Ministry of Health

Активни састојак:

OLANZAPINE 15 MG

Доступно од:

SALOMON,LEVIN & ELSTEIN LTD

АТЦ код:

N05AH03

Фармацеутски облик:

FILM COATED TABLETS

Пут администрације:

PER OS

Произведен од:

TEVA OPERATIONS POLAND SP.ZO.O

Терапеутска група:

OLANZAPINE

Терапеутске индикације:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Датум одобрења:

2011-04-01